Navigation Links
ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease
Date:1/20/2009

Collaboration to evaluate gene delivery vectors for ALS

CAMBRIDGE, Mass. and CHAPEL HILL, N.C., Jan. 20 /PRNewswire-USNewswire/ -- ALS Therapy Development Institute (ALS TDI) and Asklepios BioPharmaceutical, Inc. announced today their collaboration aimed at developing a panel of viral vectors that could be used to deliver therapeutics based on targets identified by ALS TDI that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). The collaboration between the two research centers will focus on screening and characterization of optimal delivery vectors.

"This project is an aggressive and proactive effort to develop the safest alternative therapeutic delivery options available today," reported Dr. Steve Perrin, Chief Scientific Officer at ALS TDI after a recent conference call with more than 140 members of the ALS community. "By focusing on developing therapeutic strategies while operating the largest discovery biology program for this disease, we are preparing to rapidly move potential therapeutics through the drug development process with today's patients in mind."

The custom constructed Biological Nano Particle (BNP) vectors are designed using proprietary technology developed by Asklepios. ALS TDI will evaluate the BNP vectors in a tightly-managed mouse colony that is based on mutations in a specific mutated protein, which is a cause of a genetic form of disease. BNP vectors are of interest to drug development scientists because they generally do not elicit as aggressive an immune response often associated with other viruses, and have been clinically tested. Samples from animals treated with BNP vectors will be analyzed by a variety of molecular and immunohistochemistry analysis techniques at ALS TDI to determine in which cell types each vector becomes localized in various tissue samples. This project is seen as bolstering tools available as part of a key therapeutic strategy used by A
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Collexis Healthcare to Expand Capabilities for Asklepios Group Utilizing Microsoft Solutions
2. Scientists Develop Natural Protection for Stored Foods
3. Isolation of a new gene family essential for early development
4. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Smokers More Likely to Develop Dementia
7. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
8. Ovation further advances development pipeline with new phase III epilepsy study
9. Researchers develop long-lasting growth hormone
10. Pioneer Surgical Technology Hires Vice President of New Business Development
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 Essential tremor (ET) is the ... 10 million people in the United States, and millions ... understanding what causes ET, there are no medications specifically ... Tulips for Tremor© is the International Essential Tremor Foundation’s ... and a cure for this life-altering neurological condition. , ...
(Date:6/17/2013)... initiative helped to boost organ donor registration rates, according ... Journal of Transplantation . The findings suggest that social ... variety of problems related to public health in which ... rates in the United States have remained static while ... year. To provide organs to the more than 100,000 ...
(Date:6/17/2013)... 17, 2013 "Do you think you and ... emailing or using your phone even with a hands free ... is just as dangerous as not using a hands free ... you using Facebook, texting, emailing etc." , It ... their reflexes that distract the brain, according to a study ...
(Date:6/17/2013)... 2013 The personal injury trial ... pleased to announce that firm Partners Stephen J. ... ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing on hit ... Sunday, June 23, 2013 at 7a.m. Mr. ... Kevin Burke's "Get Active" show, which highlights professionals ...
(Date:6/17/2013)... Angeles (PRWEB) June 17, 2013 According to ... Sunscreen Questions Answered,” as more and more information surfaces about ... sunscreen should become a vital part of one’s skin ... aging and cancer (Go to goo.gl/qTKZQ). , “I agree ... sunscreen,” says Dr. Simon Ourian, Medical Director of Epione Beverly ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Social media initiative may help increase organ donations 2Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... BOSTON--A duo of drugs, each targeting a prime survival ... potentially more effective than either drug alone for advanced, ... led by Dana-Farber Cancer Institute investigators. The findings ... at the annual meeting of the American Society of ...
... , FRIDAY, JUNE 3 (HealthDay News) -- People ... a heart attack or serious cardiac event, a new ... is that people with mental illness are 14 percent ... condition, researchers found. Those treatments included coronary artery ...
... June 3 (HealthDay News) -- A new strain of ... has been detected in cows, milk in the United ... the department of veterinary medicine at the University of ... new variant, which is genetically different than existing MRSA ...
... tsunami, tornado or flood strike, among the most vulnerable ... Journal of Emergency Management , researchers in New Zealand ... the age-related needs of adults with regards to the ... Tuohy and Christine Stephens of Massey University in Palmerston ...
... School of Medicine (BUSM) researchers have found that Gabapentin, ... neuropathic pain, seizures and biopolar disease in older and ... anorgasmia, or failure to experience orgasm, than previously reported. ... the American Journal of Geriatric Pharmacotherapy . ...
... nationwide hospital databases, University of Cincinnati (UC) emergency medicine ... treatment with the standard therapy for acute ischemic stroke ... Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the ... the journal Stroke . The study estimates between ...
Cached Medicine News:Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Helping the aged during natural disasters 2Health News:Use of clot-busting drug for US stroke patients doubled from 2005 to 2009 2
(Date:6/17/2013)... Actavis, Inc. (NYSE: ACT ) today ... decision of the U.S. Court of Appeals for the Eleventh ... motion to dismiss the Federal Trade Commission,s lawsuit, FTC ... result of a decision by a 5 to 3 vote.  ... adopted the traditional "rule of reason" as the standard.  ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... NEW ORLEANS , June 17, 2013 /PRNewswire/ ... for new technologies that will help improve medication ... process across its health system. ... a combination of hardware and software that helps ... to dispense and administer medications because of simpler, ...
Breaking Medicine Technology:U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
... design and architectural philosophy of the Kenneth ... stylish, targeted to a discerning customer who ... cues directly from Kenneth Cole New York ... Contemporary crystal tones in multi-laminations craft the ...
... Girl Eyewear extends that easy, breezy, beautiful ... styles, featuring an array of stylish colors, ... ,The collection is designed to target the ... who demands affordability,and high-quality, fashionable frames. The ...
... is a memory metal segment under the Charmant ... better fitting frame that's comfortable yet durable. Small ... or break won't faze CFX because it automatically ... classic to modern to sporty and is coupled ...
... Collection is the world's most extensive ... 100% pure titanium and beta-titanium frames ... superior corrosion resistance. This coupled with ... a collection that is a step ...
Medicine Products: